These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 23828743)

  • 1. The role of endocannabinoids system in fatty liver disease and therapeutic potentials.
    Alswat KA
    Saudi J Gastroenterol; 2013; 19(4):144-51. PubMed ID: 23828743
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endocannabinoids and their role in fatty liver disease.
    Mallat A; Lotersztajn S
    Dig Dis; 2010; 28(1):261-6. PubMed ID: 20460921
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endocannabinoids and liver disease. I. Endocannabinoids and their receptors in the liver.
    Mallat A; Lotersztajn S
    Am J Physiol Gastrointest Liver Physiol; 2008 Jan; 294(1):G9-G12. PubMed ID: 17975129
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endocannabinoids signaling: Molecular mechanisms of liver regulation and diseases.
    Wang M; Meng N; Chang Y; Tang W
    Front Biosci (Landmark Ed); 2016 Jun; 21(7):1488-501. PubMed ID: 27100518
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cannabinoid signaling and liver therapeutics.
    Mallat A; Teixeira-Clerc F; Lotersztajn S
    J Hepatol; 2013 Oct; 59(4):891-6. PubMed ID: 23567085
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endocannabinoid System in Hepatic Glucose Metabolism, Fatty Liver Disease, and Cirrhosis.
    Bazwinsky-Wutschke I; Zipprich A; Dehghani F
    Int J Mol Sci; 2019 May; 20(10):. PubMed ID: 31121839
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endocannabinoids as novel mediators of liver diseases.
    Mallat A; Lotersztajn S
    J Endocrinol Invest; 2006; 29(3 Suppl):58-65. PubMed ID: 16751709
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cannabinoid receptors as novel therapeutic targets for the management of non-alcoholic steatohepatitis.
    Mallat A; Lotersztajn S
    Diabetes Metab; 2008 Dec; 34(6 Pt 2):680-4. PubMed ID: 19195630
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The endocannabinoid system in advanced liver cirrhosis: pathophysiological implication and future perspectives.
    Baldassarre M; Giannone FA; Napoli L; Tovoli A; Ricci CS; Tufoni M; Caraceni P
    Liver Int; 2013 Oct; 33(9):1298-308. PubMed ID: 23890208
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The endocannabinoid system and its role in regulation of metabolism in peripheral tissues].
    Rumińska A; Dobrzyń A
    Postepy Biochem; 2012; 58(2):127-34. PubMed ID: 23214136
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endocannabinoids in liver disease.
    Tam J; Liu J; Mukhopadhyay B; Cinar R; Godlewski G; Kunos G
    Hepatology; 2011 Jan; 53(1):346-55. PubMed ID: 21254182
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cannabinoid Receptors in Metabolic Regulation and Diabetes.
    Rohbeck E; Eckel J; Romacho T
    Physiology (Bethesda); 2021 Mar; 36(2):102-113. PubMed ID: 33595385
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Innovative Therapeutic Potential of Cannabinoid Receptors as Targets in Alzheimer's Disease and Less Well-Known Diseases.
    Páez JA; Campillo NE
    Curr Med Chem; 2019; 26(18):3300-3340. PubMed ID: 29484980
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endocannabinoid Signalling in Atherosclerosis and Related Metabolic Complications.
    Guillamat-Prats R; Rami M; Herzig S; Steffens S
    Thromb Haemost; 2019 Apr; 119(4):567-575. PubMed ID: 30769363
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The emerging role of the endocannabinoid system in the pathogenesis and treatment of kidney diseases.
    Tam J
    J Basic Clin Physiol Pharmacol; 2016 May; 27(3):267-76. PubMed ID: 26280171
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of the endocannabinoid system in liver diseases.
    Caraceni P; Domenicali M; Giannone F; Bernardi M
    Best Pract Res Clin Endocrinol Metab; 2009 Feb; 23(1):65-77. PubMed ID: 19285261
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolism of endocannabinoids.
    Biernacki M; Skrzydlewska E
    Postepy Hig Med Dosw (Online); 2016 Aug; 70(0):830-43. PubMed ID: 27516570
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Perinatal maternal high-fat diet induces early obesity and sex-specific alterations of the endocannabinoid system in white and brown adipose tissue of weanling rat offspring.
    Almeida MM; Dias-Rocha CP; Souza AS; Muros MF; Mendonca LS; Pazos-Moura CC; Trevenzoli IH
    Br J Nutr; 2017 Nov; 118(10):788-803. PubMed ID: 29110748
    [TBL] [Abstract][Full Text] [Related]  

  • 19. From endocannabinoid profiling to 'endocannabinoid therapeutics'.
    Ligresti A; Petrosino S; Di Marzo V
    Curr Opin Chem Biol; 2009 Jun; 13(3):321-31. PubMed ID: 19497779
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The pharmacology of cannabinoid receptors and their ligands: an overview.
    Pertwee RG
    Int J Obes (Lond); 2006 Apr; 30 Suppl 1():S13-8. PubMed ID: 16570099
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.